检索范围:
排序: 展示方式:
Effects and mechanisms of acupuncture on women related health
《医学前沿(英文)》 doi: 10.1007/s11684-023-1051-5
《医学前沿(英文)》 2023年 第17卷 第2期 页码 231-239 doi: 10.1007/s11684-022-0939-9
关键词: neoadjuvant radiotherapy oligometastatic prostate cancer radical prostatectomy
《医学前沿(英文)》 2022年 第16卷 第5期 页码 736-744 doi: 10.1007/s11684-021-0870-5
关键词: pneumoconiosis randomized controlled trials traditional Chinese medicine
邱毅,王磊光,于玲
《中国工程科学》 2014年 第16卷 第5期 页码 39-46
为了观察新型立体式网状宫内节育器(3-DR-IUD)的避孕效果及副反应,将152 例志愿受试者随机分为两组,即接受3-DR-IUD组和放置元宫药铜宫内节育器(2-D-IUD)组,每组各76 例,常规放置3-DR-IUD和2-D-IUD。分别于术后1 个月、3 个月、6 个月和12 个月进行随访,了解放置宫内节育器(IUD)后副反应(如腹痛、腰痛、阴道出血持续时间及出血量、白带等)的发生率、带器妊娠率、IUD脱落率、因症取出率、续用率及避孕效果,并利用B超、X光腹部平片检查3-DR-IUD位置等。两组各76 例均成功放置了IUD,术中均无明显疼痛。3-DR-IUD组术后出现白带增多、月经期延长、不规则出血、月经量增多及腰腹部疼痛等副反应6例(7.9%),而2-D-IUD组出现31例(40.8%),两组比较差异有统计学意义(P<0.000 1)。3-DR-IUD 组无脱落,无带器妊娠者,3 个月时因对硅橡胶过敏取出1 例,12 个月时终止率为1.3 %,续用率为98.7 %(75/76);2-DIUD组终止率为13.2 %,续用率为86.8 %(66/76),两组比较差异有统计学意义(P=0.009)。实验结果表明,3-DR-IUD具有很好的避孕效果,术后副反应轻微,可为育龄妇女提供新的、安全、高效的IUD。
Partial portacaval shunt with H-grafts to treat portal hypertension
XU Geliang, HU Hejie, LI Jiansheng, YANG Shugao, CHAI Zhongpei, XU Rongnan
《医学前沿(英文)》 2007年 第1卷 第3期 页码 279-281 doi: 10.1007/s11684-007-0053-z
关键词: diameter clinical efficacy bleeding pericardial devascularization Forty-three
A review of the safety and efficacy of current COVID-19 vaccines
《医学前沿(英文)》 2022年 第16卷 第1期 页码 39-55 doi: 10.1007/s11684-021-0893-y
关键词: COVID-19 SARS-CoV-2 vaccine safety efficacy effectiveness immunogenicity
Heterogeneous influence of individuals’ behavior on mask efficacy in gathering environments
《工程管理前沿(英文)》 页码 550-562 doi: 10.1007/s42524-022-0193-5
关键词: COVID-19 masks behavioral heterogeneity asymptomatic infection
Retrospective study of the efficacy and complication of thoracoabdominal incision for nephrectomy: a
Minggen YANG, Xiaokun ZHAO
《医学前沿(英文)》 2009年 第3卷 第2期 页码 191-196 doi: 10.1007/s11684-009-0026-5
Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary
null
《医学前沿(英文)》 2013年 第7卷 第2期 页码 255-263 doi: 10.1007/s11684-012-0227-1
The efficacy of ursodeoxycholic acid (UDCA) on long-term outcome of primary biliary cirrhosis (PBC) has been less documented in Chinese cohort. We aimed to assess the therapeutic effect of UDCA on Chinese patients with PBC. In the present study, 67 patients with PBC were treated with UDCA (13–15 mg?kg-1?day-1) and followed up for 2 years to evaluate the changes of symptoms, laboratory values and histological features. As the results indicated, fatigue and pruritus were obviously improved by UDCA, particularly in patients with mild or moderate symptoms. The alkaline phosphatase and γ-glutamyl transpetidase levels significantly declined at year 2 comparing to baseline values, with the most profound effects achieved in patients at stage 2. The levels of alanine aminotransferase and aspartate aminotransferase significantly decreased whereas serum bilirubin and immunoglobulin M levels exhibited no significant change. Histological feature was stable in patients at stages 1–2 but still progressed in patients at stages 3–4. The biochemical response of patients at stage 2 was much better than that of patients at stages 3–4. These data suggest that, when treated in earlier stage, patients in long-term administration of UDCA can gain favorable results not only on symptoms and biochemical responses but also on histology. It is also indicated that later histological stage, bad biochemical response and severe symptom may be indicators of poor prognosis for UDCA therapy.
关键词: primary biliary cirrhosis ursodeoxycholic acid Chinese biochemical response therapeutic efficacy
“通过肠道菌群增强临床功效:中药的新领域”的勘误[工程5(2019)40–49] Corrigendum
Yan-Meng Lu, Jiao-Jiao Xie, Cong-Gao Peng, Bao-Hong Wang, Kai-Cen Wang, Lan-Juan Li
《工程(英文)》 2019年 第5卷 第4期 页码 811-812 doi: 10.1016/j.eng.2019.05.004
基于整合临床和动物实验的小分子筛选平台揭示经典方剂茵陈蒿汤治疗黄疸证显效状态下的活性化合物及潜在作用靶点 Article
熊辉, 张爱华, 郭雅静, 周小航, 孙晖, 杨乐, 方衡, 闫广利, 王喜军
《工程(英文)》 2021年 第7卷 第9期 页码 1293-1305 doi: 10.1016/j.eng.2020.12.016
中药方剂化学组成高度复杂,其药理作用具有多成分、多靶点的特点,使得阐明其生物活性化合物极具挑战性。茵陈蒿汤被广泛用于治疗黄疸相关疾病。尽管近年来茵陈蒿汤的药效及活性成分被不断证实,但仍然缺乏对其效应成分、效应机制和功能靶点的深入系统分析,尤其是临床研究方面。本研究建立了一个整合临床和动物实验平台用于发现茵陈蒿汤的活性化合物和潜在靶点。首先采用基于超高效液相色谱-四极杆飞行时间质谱(UPLC-Q-ToF-MS)技术的代谢组学方法结合中药血清药物化学方法揭示茵陈蒿汤的血清代谢谱和化学成分谱。此外,通过网络药理学和智能途径分析平台构建化合物-靶标-通路关联网络。最终发现茵陈蒿汤中8 个活性小分子与5 个核心靶点极度相关,并通过酶联免疫吸附测定实验进行生物学验证。结果表明茵陈蒿汤通过靶向胆固醇7α-羟化酶(CYP7A1)、多药耐药相关蛋白2(ABCC2)、多药耐药相关蛋白3(ABCC3)、尿苷二磷酸葡萄糖醛酸基转移酶1A1(UGT1A1)和法尼醇X受体(FXR)来调节包括初级胆汁酸生物合成、卟啉和叶绿素代谢以及胆汁分泌在内的代谢通路,从而发挥利胆退黄的作用。该整合策略可以成功地用于中药方剂活性小分子及其作用靶点的发现。
肠道微生态——探索中药临床疗效的新思路 Review
陆艳蒙, 谢娇娇, 彭聪高, 王保红, 王恺岑, 李兰娟
《工程(英文)》 2019年 第5卷 第1期 页码 40-49 doi: 10.1016/j.eng.2018.11.013
自古以来,中药在疾病预防、症状缓解和健康改善等方面发挥了重要作用。然而,复杂的成分和尚未明确的机制阻碍了中药的广泛推广和应用。越来越多的研究表明,和人体健康息息相关的肠道微生态与中药的疗效有关,因此从肠道微生态的角度去探索中药可能是打开中药奥秘的金钥匙。肠道菌群主要通过以下4个生理途径中发挥作用:参与宿主代谢、调节系统免疫、维持胃肠道稳态以及影响脑功能和宿主行为。本文回顾了中药与慢性肝病、溃疡性结肠炎、肥胖和2型糖尿病等疾病之间的联系,从肠道微生态的角度阐明其潜在的机制。未来,我们需要进一步的研究和更完善的实验设计,以揭示中药与肠道菌群之间相互作用的具体机制,并为中药的创新研究提供新的思路。
《医学前沿(英文)》 2023年 第17卷 第3期 页码 493-502 doi: 10.1007/s11684-022-0946-x
关键词: ALK fusion next-generation sequencing fluorescence in situ hybridization immunohistochemistry variant allele frequency intratumoral heterogeneity targeted therapy
Protective efficacy of vaccination with NcMIC3 and NcMIC8 against
Taotao ZHANG, Xiao ZHANG, Qun LIU, Jianhai XU, Jing LIU
《农业科学与工程前沿(英文)》 2019年 第6卷 第2期 页码 188-196 doi: 10.15302/J-FASE-2019253
Microneme proteins (MICs) are important for Apicomplexan parasite invasion due to their adhesion to host cells. Several studies have indicated that MIC3 and MIC8 are important adhesion factors and potential vaccine candidates against neosporosis. In this study, we evaluated the protective efficacy of recombinant proteins and DNA vaccines of NcMIC3 and NcMIC8. BALB/c mice were immunized with rNcMIC3, rNcMIC8, pcDNA3.1-NcMIC3 and pcDNA3.1-NcMIC8 respectively, and challenged with tachyzoites. The immune responses were evaluated through cytokine, antibody measurements and the parasite burden in the mice brain tissues. Serological analysis showed that recombinant protein vaccines induced higher levels of immunoglobulin G (IgG) than other groups. The percentage of IgG1 and IgG2a in the recombinant protein groups was higher than the other groups, and with a predominance of IgG1 over IgG2a, suggesting that recombinant protein vaccines elicited a Th2-type immune response, while DNA vaccines mainly produce a Th1-type immune response. In addition, mice immunized with rNcMIC3 and rNcMIC8 a had lower parasite burden in brain tissue compared with the other groups. These results demonstrate that rNcMIC3 and rNcMIC8 could induce humoral and Th2-type immune response, leading to a considerable level of resistance against neosporosis.
标题 作者 时间 类型 操作
Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer: safety and efficacy outcomesfrom an open-label, dose-escalation, single-center, phase I/II clinical trial
期刊论文
Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients
期刊论文
Partial portacaval shunt with H-grafts to treat portal hypertension
XU Geliang, HU Hejie, LI Jiansheng, YANG Shugao, CHAI Zhongpei, XU Rongnan
期刊论文
Retrospective study of the efficacy and complication of thoracoabdominal incision for nephrectomy: a
Minggen YANG, Xiaokun ZHAO
期刊论文
Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary
null
期刊论文
“通过肠道菌群增强临床功效:中药的新领域”的勘误[工程5(2019)40–49]
Yan-Meng Lu, Jiao-Jiao Xie, Cong-Gao Peng, Bao-Hong Wang, Kai-Cen Wang, Lan-Juan Li
期刊论文
Potential unreliability of ALK variant allele frequency in the efficacy prediction of targeted therapy
期刊论文